These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3904425)

  • 1. Bone disease and aluminum: pathogenic considerations.
    Goodman WG
    Am J Kidney Dis; 1985 Nov; 6(5):330-5. PubMed ID: 3904425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig.
    Sedman AB; Alfrey AC; Miller NL; Goodman WG
    J Clin Invest; 1987 Jan; 79(1):86-92. PubMed ID: 3793934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of osteomalacia in the rat with acute aluminum toxicity.
    Rodriguez M; Felsenfeld AJ; Llach F
    J Bone Miner Res; 1989 Oct; 4(5):687-96. PubMed ID: 2816514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term aluminum administration in the rat: reductions in bone formation without osteomalacia.
    Goodman WG
    J Lab Clin Med; 1984 May; 103(5):749-57. PubMed ID: 6715954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication.
    Charhon SA; Chavassieux PM; Chapuy MC; Boivin GY; Meunier PJ
    J Lab Clin Med; 1985 Aug; 106(2):123-31. PubMed ID: 2410522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of aluminium in experimental osteomalacia. Preliminary results: Aluminium content and bone mineralization.
    Costantini S; Bonucci E; Mocetti P; Ballanti P; Giordano R; Vernillo I; Ioppolo A; Mantovani A; Stasolla D
    Ann Ist Super Sanita; 1986; 22(2):689-95. PubMed ID: 3752831
    [No Abstract]   [Full Text] [Related]  

  • 7. Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs.
    Quarles LD; Dennis VW; Gitelman HJ; Harrelson JM; Drezner MK
    J Clin Invest; 1985 May; 75(5):1441-7. PubMed ID: 3998143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental aluminum-induced bone disease: studies in vivo.
    Goodman WG
    Kidney Int Suppl; 1986 Feb; 18():S32-6. PubMed ID: 3517461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of etidronate-mediated suppression of bone remodeling on aluminum-induced de novo bone formation.
    Quarles LD; Drezner MK
    Endocrinology; 1992 Jul; 131(1):122-6. PubMed ID: 1611990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histomorphometric evidence of deleterious effect of aluminum on osteoblasts.
    de Vernejoul MC; Belenguer R; Halkidou H; Buisine A; Bielakoff J; Miravet L
    Bone; 1985; 6(1):15-20. PubMed ID: 2581595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term aluminum administration in the rat. Effects on bone formation and relationship to renal osteomalacia.
    Goodman WG; Gilligan J; Horst R
    J Clin Invest; 1984 Jan; 73(1):171-81. PubMed ID: 6690476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of aluminum on rat bone cell populations.
    Kidder LS; Klein GL; Gundberg CM; Seitz PK; Rubin NH; Simmons DJ
    Calcif Tissue Int; 1993 Nov; 53(5):357-61. PubMed ID: 8287325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological effects of aluminum on normal dogs: studies on the isolated perfused bone.
    Galceran T; Finch J; Bergfeld M; Coburn J; Martin K; Teitelbaum S; Slatopolsky E
    Endocrinology; 1987 Jul; 121(1):406-13. PubMed ID: 3036473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The case against aluminum affecting parathyroid function.
    Alfrey AC
    Am J Kidney Dis; 1985 Nov; 6(5):309-12. PubMed ID: 4061453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of aluminum on mineralization during matrix-induced bone development.
    Talwar HS; Reddi AH; Menczel J; Thomas WC; Meyer JL
    Kidney Int; 1986 May; 29(5):1038-42. PubMed ID: 3723926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case for parathyroid hormone.
    Mayor GH
    Am J Kidney Dis; 1985 Nov; 6(5):306-8. PubMed ID: 3904422
    [No Abstract]   [Full Text] [Related]  

  • 17. Aluminum-related osteomalacia in renal-failure patients.
    Vick KE; Johnson CA
    Clin Pharm; 1985; 4(4):434-9. PubMed ID: 3899471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aluminum on bone and cell localization.
    Cournot-Witmer G; Plachot JJ; Bourdeau A; Lieberherr M; Jorgetti V; Mendes V; Halpern S; Hemmerle J; Drüeke T; Balsan S
    Kidney Int Suppl; 1986 Feb; 18():S37-40. PubMed ID: 3457993
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and reversibility of aluminum-induced bone lesion in the rat.
    Ott SM; Feist E; Andress DL; Liu CC; Sherrard DJ; Alfrey AC; Slatopolsky E; Howard GA
    J Lab Clin Med; 1987 Jan; 109(1):40-7. PubMed ID: 3794513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
    Visser WJ; Van de Vyver FL
    Clin Nephrol; 1985; 24 Suppl 1():S30-6. PubMed ID: 3915958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.